Tandem糖尿病护理 TNDM 深 沪
等待开盘 10-01 09:30:00 美东时间
12.14
+0.350
+2.97%
华盛通- 最 高12.185
- 今 开11.75
- 成交量 156.12万股
- 最 低 11.46
- 昨 收 11.79
- 总市值 8.20亿
- 52周最高 38.94
- 市盈率 静 --
- 换手率 2.31%
- 52周最低 9.98
- 委 比 -25.35%
- 总股本 6756.95万
- 历史最高 302.50
- 量 比 1.08
- 振 幅 6.15%
- 历史最低 2.14
- 每 手 1
- 风险率 9.99%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅207.38%！GoldMining获HC Wainwright升目标价至3.75美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持GoldMining"买入"评级，目标价从3.25美元升至3.75美元；摩根士丹利：维持Crinetics Pharmaceuticals"超配"评级，目标价从65美元升至77美元
09-30 14:16
Canaccord Genuity Maintains Buy on Tandem Diabetes Care, Maintains $24 Price Target
Canaccord Genuity analyst William Plovanic maintains Tandem Diabetes Care (NASDAQ: TNDM) with a Buy and maintains $24 price target.
09-29 22:03
Jim Cramer: This Is The Right Time To Buy This Energy Stock
Mad Money's Jim Cramer looks at Phillips 66 and Intuitive Surgical, as well as Tandem Diabetes Care and Cintas.
09-11 19:50
Beyond The Numbers: 12 Analysts Discuss Tandem Diabetes Care Stock
In the last three months, 12 analysts have published ratings on Tandem Diabetes...
09-09 02:01
Oppenheimer Maintains Outperform on Tandem Diabetes Care, Lowers Price Target to $22
Oppenheimer analyst Steven Lichtman maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Outperform and lowers the price target from $44 to $22.
09-08 22:40
美股大行评级 | DoorDash获上调目标价从230美元升至300美元； 摩根大通上调Shopify目标价从115美元升至179美元
今日重点评级关注：HC Wainwright & Co.：维持FibroGen"买入"评级，目标价从10美元升至43美元；摩根大通：维持Cogent Biosciences"超配"评级，目标价从29美元升至30美元
08-08 09:34
Tandem Diabetes Care shares are trading lower after the company reported mixed Q2 financial results and narrowed its FY25 sales guidance below estimates.
Tandem Diabetes Care shares are trading lower after the company reported mixed ...
08-07 05:41
Tandem Diabetes Care Narrows FY2025 Sales Guidance from $997.000M-$1.007B to $1.000B vs $1.004B Est
Tandem Diabetes Care (NASDAQ:TNDM) narrows FY2025 sales outlook from $997.000 million-$1.007 billion to $1.000 billion vs $1.004 billion estimate.
08-07 04:26
Earnings Scheduled For August 6, 2025
Companies Reporting Before The Bell • Lineage (NASDAQ:LINE) is likely to report...
08-06 16:33
Citigroup Downgrades Tandem Diabetes Care to Sell, Lowers Price Target to $14
Citigroup analyst Joanne Wuensch downgrades Tandem Diabetes Care (NASDAQ:TNDM) from Neutral to Sell and lowers the price target from $24 to $14.
07-09 20:07
